Your browser doesn't support javascript.
loading
HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti-HER-2/neu (4B5).
Horimoto, Yoshiya; Onagi, Hiroko; Watanabe, Junichiro; Hayashi, Takuo.
Afiliação
  • Horimoto Y; Department of Human Pathology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
  • Onagi H; Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
  • Watanabe J; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan.
  • Hayashi T; Department of Human Pathology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Pathol Int ; 74(2): 99-101, 2024 02.
Article em En | MEDLINE | ID: mdl-38197542
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article